Impact of Follicular and Blood G-CSF During a Natural Cycle of IVF
NCT ID: NCT01668225
Last Updated: 2022-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
152 participants
OBSERVATIONAL
2012-03-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of G-CSF Supplemented IVF Medium in Patients Undergoing IVF
NCT02651285
Gcsf Injection in Women With Repeated Implantaiton Failure
NCT02149277
Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF
NCT01202643
The Role of Granulocyte Colony Stimulating Factor in Embryo Transfer Outcomes
NCT06174298
Use of GM-CSF Supplemented IVF Medium in Patients With Recurrent Implantation Failure
NCT01718210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
G-CSF FIV nat
Patient following a natural In Vitro Fecondation cycle
Blood test
Taking blood sample of the patient during the day 3, triggering day, oocyte collection day and pregnancy test day.
Taking the follicular fluid during the oocyte collection day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood test
Taking blood sample of the patient during the day 3, triggering day, oocyte collection day and pregnancy test day.
Taking the follicular fluid during the oocyte collection day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women natural In Vitro Fecondation
18 Years
43 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinique Ovo
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacques Kadoch, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique Ovo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ovo Fertilité
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OVO-11-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.